Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00506727 · ClinicalTrials.gov registry record · Phase 4
Analog Classroom Study Comparison of ADDERALL XR With STRATTERA in Children Aged 6-12 With ADHD
A Phase 4 study, sponsored by Shire.
- Completed
- Registry status
- Phase 4
- Development phase
- 215
- Enrollment target
NCT00506727 is a Phase 4 study that has completed, run by Shire. The registered enrollment target is 215 participants.
The verdict
NCT00506727, a Phase 4 study, has completed, sponsored by Shire.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 215 participants
- Enrollment target
Study Summary
Evaluate the behavioral effects of ADDERALL XR versus STRATTERA under controlled conditions utilizing the SKAMP deportment scale.
Interventions
- DRUG Atomoxetine hydrochloride
- DRUG Mixed amphetamine salts (ADDERALL XR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 215 participants |
| Start Date | 2003-08-05 |
| Est. Completion | 2004-07-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00506727
The ClinicalTrials.gov registry entry for NCT00506727 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 215 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Atomoxetine hydrochloride is the first listed.
NCT00506727 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00506727 about?
NCT00506727 is a clinical study titled "Analog Classroom Study Comparison of ADDERALL XR With STRATTERA in Children Aged 6-12 With ADHD". Evaluate the behavioral effects of ADDERALL XR versus STRATTERA under controlled conditions utilizing the SKAMP deportment scale.
What is the current status of trial NCT00506727?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 215 participants. The study started on 2003-08-05. Estimated completion is 2004-07-02.
What interventions are being tested in trial NCT00506727?
The interventions under investigation include: Atomoxetine hydrochloride (DRUG), Mixed amphetamine salts (ADDERALL XR) (DRUG).
Who is sponsoring clinical trial NCT00506727?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.